Introducing Cytiva
Previously GE Healthcare Life Sciences, Cytiva will help accelerate growth and innovation in biological therapies
Cytiva, a global provider of technologies and services that help advance and accelerate the development and manufacture of therapeutics, launches. Previously GE Healthcare Life Sciences, Cytiva has nearly 7,000 employees and operations in 40 countries and is part of the Danaher Corporation Life Sciences platform.
Emmanuel Ligner, President of Cytiva, says: “Our foundation of scientific expertise, our team, and our solid customer base place Cytiva in the right position to invest, develop, and accelerate growth in the industry. Our passion for helping bring life-changing therapies to patients is unwavering, and we will continue to introduce innovative technologies to the market which improve productivity for our customers.”
Accelerating growth, productivity, and innovation in the sector are major strategic focus areas for the company, as global demand for personalized and advanced biological therapies is ever-increasing. Cytiva drives customer-centered innovation, from idea to commercial development stages, with facilities across Asia, Europe, and the Americas. It also has centers for customer collaboration and training to enable the development of new therapies, such as the Testa Center in Uppsala, Sweden and with the University of Technology at Sydney.
Cytiva will also continue to pursue collaborations for research, such as the center for advanced biological innovation and manufacturing in Boston with Harvard, MIT, teaching hospitals, and industry partners Fujifilm Diosynth Biotechnologies, and Alexandria Real Estate Equities, Inc.
Cytiva’s diverse portfolio includes well-recognized brands such as ÄKTA, Amersham, Biacore, FlexFactory, HyClone, MabSelect, Sefia, Whatman, Xcellerex and Xuri. The portfolio spans a full range of instruments, consumables, digital and enterprise solutions and services for research, process development, and complete manufacturing workflows that scale according to customers’ needs.
Other news from the department business & finance
